Technology
Health
Biotechnology

Cytori Therapeutics

$0.2808
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0095 (3.40%) Today
-$0.0081 (-2.80%) After Hours

Why Robinhood?

You can buy or sell CYTX and other stocks, options, ETFs, and crypto commission-free!

About

Cytori Therapeutics Inc. Common Stock, also called Cytori Therapeutics, is a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. Read More It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Employees
37
Headquarters
San Diego, California
Founded
1996
Market Cap
4.28M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
550.08K
High Today
$0.34
Low Today
$0.27
Open Price
$0.27
Volume
936.14K
52 Week High
$2.83
52 Week Low
$0.215

Collections

Technology
Health
Biotechnology
Therapy
Medical
US
North America

Earnings

-$0.59
-$0.36
-$0.12
$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.30 per share
Actual
-$0.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.